Document is current
Any future updates will be listed below
-
Authors
Weiss-Tessbach, Matthias https://orcid.org/0000-0003-0131-9091
Haider, Teresa https://orcid.org/0000-0002-0497-4369
Gowran, Aoife https://orcid.org/0000-0003-1098-3357
Schubert, Lorenz https://orcid.org/0000-0001-9181-8614
Mühlbacher, Jakob https://orcid.org/0000-0002-8592-8259
Brankovic, Jelena https://orcid.org/0009-0001-6243-9196
Wahrmann, Markus https://orcid.org/0000-0002-1301-8694
Jilma, Bernd https://orcid.org/0000-0001-5652-7977
Boehm, Thomas https://orcid.org/0000-0002-8294-0797
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 5 November 2024
Revised: 31 March 2025
Accepted: 4 April 2025
First Online: 29 April 2025
Declarations
:
: TB and BJ are named inventors of a patent describing the heparin-binding motif rhDAO mutants (WO2020169577A1). The other authors declare that they have no conflicts of interest.
